Vincent CA, Nissen I, Dakhel S, Hornblad A, et al. Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide. BMC Cancer 2023;23:945.
PMID: 37803333